share_log

Stifel Upgrades Profound Medical to Buy, Raises Price Target to $12

Benzinga ·  Jul 16 05:30

Stifel analyst Rick Wise upgrades Profound Medical (NASDAQ:PROF) from Hold to Buy and raises the price target from $9 to $12.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment